Federal Health Grants

This grant provides funding to researchers for planning clinical trials that improve cancer prevention, treatment, and care, addressing gaps in knowledge and feasibility to enhance study design and outcomes.

This funding opportunity supports healthcare systems in implementing and studying coordinated pain care models that improve pain management for underserved populations through collaborative, evidence-based approaches.

This funding opportunity supports high-risk, multi-center clinical trials aimed at addressing significant health issues related to diabetes, digestive diseases, and kidney disorders, encouraging diverse institutions to apply for impactful research that can transform clinical practices.

THIS IS NOT A FUNDING OPPORTUNITY. The United States Agency for International Development (USAID), Bureau for Global Health (GH), Office of Acquisition and Assistance, hereby issues this Request for Information (RFI) regarding Regional Implementation Science (IS) Research for Improved Sexual and Reproductive Health (SRH) Programs. USAID is seeking information from interested parties located in West and Central Africa and East and Southern Africa to help refine the focus of this activity design. The potential new activity will utilize USAIDs New Partnership Initiative Global Health Annual Program Statement (NPI GH APS) number 7200AA19APS00013 to ensure local and regional partners are in the lead in driving research, uptake, and capacity.Interested parties are requested to respond using Google Forms links provided in the attached RFI documents by August 13, 2024, 5:00AM EDT. See attached RFI documents (English and French Versions) for the RFI terms, background and submission instructions. Interested parties may submit their responses to the RFI questions in English or French.

This FOA solicits the development of theories, computational models, and analytical tools to derive understanding of brain function from complex neuroscience data. Proposed projects could develop tools to integrate existing theories or formulate new theories; conceptual frameworks to organize or fuse data to infer general principles of brain function; multiscale/multiphysics models to generate new testable hypotheses to design/drive future experiments; new analytical methods to either support or refute a stated hypothesis about brain function. It is expected that the tools developed under this FOA will be made widely available to the neuroscience research community for their use and modification. Investigative studies should be limited to model parameter estimation and/or validity testing of the tools being developed.

THIS IS NOT A FUNDING OPPORTUNITY. The United States Agency for International Development (USAID) posts this Request for Information (RFI) to seek information/inputs from capable and interested organizations for an upcoming global social and behavior change (SBC) activity designed to advance local ownership and leadership of high-quality, evidence-informed SBC programs to improve health and development outcomes. A five-year activity is anticipated through full and open competition.Interested parties are requested to respond using the address provided on the attached RFI by August 21, 2023, 9:00AM EST.

Grant Title: Centers on the Demography and Economics of Aging, Including Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) (D and E Centers) (P30 Clinical Trial Optional) aims to support interdisciplinary research centers that focus on the social science aspects of aging, particularly related to health disparities, economic impacts, and caregiving for dementia, while fostering collaboration among diverse scholars and institutions.

The National Cancer Institute (NCI) intends to issue the U54 Specialized Programs of Research Excellence in Cancer Health Disparities and Minority Health (CHD-MH SPORE) notice of funding opportunity (NOFO). The program will support a network of multidisciplinary, multi-institutional U54 CHD-MH SPOREs, which are multi-project awards uniquely focused on health disparities and/or minority health translational research for improved prevention, early detection, diagnosis, and treatment of cancer in populations who are underserved. U54 CHD-MH SPOREs can investigate more than one cancer type in underserved populations, including groups of highly related cancers (e.g., gastrointestinal or head and neck). The research supported through this program must be translational and must stem from research on human biology, addressing the interplay of various determinants of health with the biology of the disease. U54 CHD-MH SPORE projects must have the goal of reaching a translational human endpoint within the project period of the grant, which may include a clinical trial. This Notice of Intent to Publish is being provided to allow sufficient time for applicants to develop strong applications. The NOFO is expected to be published in late winter 2024 with only one expected application due date in late September 2024.

This grant provides funding to local organizations in Myanmar to strengthen tuberculosis screening, testing, and treatment services, particularly through private healthcare providers and community-based initiatives.

This grant provides funding for research projects that explore the complex processes of cancer metastasis, encouraging collaboration among institutions to improve understanding and treatment of metastatic diseases.

This funding opportunity supports research projects aimed at improving health outcomes for Native American populations by developing and testing culturally appropriate health interventions.

This funding opportunity supports research on policies affecting tobacco, alcohol, and cannabis use in underserved communities, aiming to promote health equity and reduce disparities in substance exposure and use.

The purpose of the NHLBI Career Transition Award (K22) program is to provide highly qualified postdoctoral fellows and other doctoral-level researchers still in training in the NHLBI Division of Intramural Research the opportunity to transition their research programs to extramural institutions as junior investigators. To achieve these objectives, the NHLBI Career Transition Award will support two phases of research: a mentored intramural phase (up to two years) and an extramural phase (three years), for a total of five years of combined support. Transition from the intramural phase of support to the extramural phase is not automatic. Approval of the transition will be based on the success of the awardee's research program during the mentored phase as determined by an NHLBI progress review, which will include an evaluation of a research plan to be carried out at the extramural institution. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or a separate ancillary clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor. Applicants proposing to serve as lead investigator of a clinical trial or an ancillary study to an ongoing clinical trial, should apply to the companion FOA, PAR-22-040 "NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22- Clinical Trial Required).

This funding opportunity provides financial support for research aimed at improving the spread and implementation of effective health interventions, particularly in underserved communities, with a focus on promoting health equity and addressing health disparities.

Education programs supported by this initiative will equip scientists, health professionals and academics in low and middle-income countries with in-depth knowledge of the ethical principles, processes and policies related to international clinical and public health research.The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that foster a better understanding of the ethics of biomedical, behavioral and clinical research and its implications. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on: Courses for Skills Development Mentoring Activities Research or Practicum Experiences The Fogarty International Bioethics Training Program aims to increase the number of research intensive institutions in low- and middle-income countries (LMICs) that can provide advanced education in international research ethics. This FOA will support innovative LMIC master's level research ethics education programs proposing integrated activities to develop culturally appropriate foundational research ethics curriculum, research ethics career skills development courses, ethics research or practicum experiences, and effective mentoring approaches. Education programs supported by this initiative should equip scientists, health professionals and academics in these countries with in-depth knowledge of the ethical principles, processes and policies related to international research. Programs should be designed to strengthen the critical competencies needed to provide research ethics education, ethical review leadership and expert consultation to LMIC researchers, their academic or research institutions, governments and international health research organizations to enhance the application of research ethics principles.

This funding opportunity provides financial support for Kuwaiti non-profits, educational institutions, and individuals to create projects that strengthen cultural and educational ties between the United States and Kuwait.

This funding opportunity supports the establishment of a central coordinating center to enhance collaboration, data sharing, and community engagement in cancer immunoprevention research, with a focus on inclusivity and support for early-career scientists.

This funding opportunity supports researchers in developing new screening methods and treatments for serious genetic conditions in newborns that could greatly benefit from early detection and intervention.

The "Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research" grant aims to encourage existing NCI P30 centers to enhance their current research by integrating new technologies from the NCI Innovative Molecular Analysis Technologies program, with the goal of advancing cancer research and promoting scientific discovery.

This grant provides funding to state and local governments, nonprofits, and educational institutions to help enroll eligible children in Medicaid and CHIP while improving their retention in these programs.